statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Guidelines highlight the importance of risk prediction and personalized treatment to reduce riskLONDON and SALT LAKE CITY, March 14, 2024 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE...

KidneyIntelX  included in Final KDIGO 2024 Clinical Guideline for Chronic Kidney Disease (CKD)

Regenxbio, Quoin Pharmaceuticals, Renalytix among healthcare movers...

Regenxbio, Quoin Pharmaceuticals, Renalytix among healthcare movers

Titoli in rialzo
Il titolo Quoin Pharmaceuticals (NASDAQ:QNRX) salito del 129,59% a 6,36 dollari durante la sessione pre-market di luned .
Le azioni di Renalytix (NASDAQ:RNLX) hanno guadagnato il...

12 titoli sanitari in movimento, pre-market del 04/03/2024

LONDON and SALT LAKE CITY, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) (the Company ), an artificial intelligence-enabled in vitro diagnostics company, focused on...

Renalytix Reports Financial Results for Second Quarter of Fiscal Year 2024

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining around 150 points on Thursday.
The Dow traded up 0.42% to 38,585.09 while the NASDAQ fell 0.19% to 15,828.29. The...

Crude Oil Rises Over 2%; Renalytix Shares Plummet

Renalytix surges after Medicare draft decision on lead product...

Renalytix surges after Medicare draft decision on lead product

LONDON and SALT LAKE CITY, Feb. 09, 2024 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) (the Company ) today announced that the Company will be participating in the upcoming BTIG...

Renalytix to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

Renalytix Plc (NASDAQ:RNLX  Get Free Report) saw a significant increase in short interest during the month of January. As of January 15th, there was short interest totalling 672,200 shares, an...

Renalytix Plc (NASDAQ:RNLX) Short Interest Up 145.3% in January

Electronic health record deployment of KidneyIntelX was associated with clinical actions that slowed progression of chronic kidney disease and improved Type 2 diabetes control in just 12 months...

New published data demonstrates KidneyIntelX  has broad implications for winning war on chronic kidney disease

Renalytix Plc engages in the manufacturing of medical devices and equipment. It includes the development of artificial intelligence-enabled clinical diagnostic solutions for kidney disease. The company was founded by James McCullough on March 15, 2018 and is headquartered in New York, NY.

Volume	88,548.00
52-Wk High	$4.04
52-Wk Low	$0.2449

Period	Estimated	Reported	Surprise	Result
Q3'24	-$0.09	--	--	N/A
Q2'24	-$0.09	-$0.09	0.28%	BEAT
Q1'24	-$0.11	-$0.11	-4.76%	MISSED
Q4'23	-$0.12	-$0.12	-1.81%	MISSED
Q3'23	-$0.11	-$0.14	-24.89%	MISSED

RNLX Renalytix AI Plc - ADR

About

Feed

News

Sentiment

Earnings

Fundamentals